AngioDynamics supports SIRF's Discovery Campaign to expand minimally invasive medicine

The Society of Interventional Radiology Foundation's Discovery campaign will benefit from a $500,000 pledge by new "Futurist" level supporter, medical device manufacturer AngioDynamics.

"Initiatives of this kind continue to reinforce opportunities for investment in the specialty's future, with funding that supports grants, research consensus panels, registries, clinical trials and educational programming," said John A. Kaufman, M.D., FSIR, chair of the SIR Foundation board of directors. "Our specialty's hallmarks are investigation and innovation, and the impact that major corporate support has on the future of the specialty is transformational," noted Kaufman, who is also a professor and Frederick S. Keller Chair of Interventional Radiology at the Dotter Interventional Institute in Portland, Ore.

"AngioDynamics has always shared the SIR Foundation's passion for fueling innovation in patient care through research and education. Our company is committed to being a partner in patient care with interventional radiologists through our support of the SIR Foundation and its pursuit of new discoveries in minimally invasive treatments," said Joseph DeVivo, Angiodynamics' president and chief executive officer. "This Discovery Campaign commitment underscores our long-time dedication to interventional radiologists and to advancing the treatment of millions of patients worldwide," he added.

The Discovery Campaign was launched initially in 2007 with an SIR membership phase. In 2010, the campaign began outreach to the medical technology industry for support. For information about the Society of Interventional Radiology, a national organization of nearly 4,700 doctors, scientists and allied health professionals dedicated to improving health care through minimally invasive treatments.